Discontinued — last reported Q1 '26

Geographic · Sales

Latin America — Sales

Merck & Co. Latin America — Sales increased by 2.3% to $874.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.4%, from $792.00M to $874.00M. Over 4 years (FY 2021 to FY 2025), Latin America — Sales shows an upward trend with a 11.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates successful product adoption or market expansion in the region, while a decrease may signal competitive pressure, regulatory hurdles, or adverse macroeconomic conditions.

Detailed definition

This metric represents the total revenue generated from the sale of pharmaceutical products and services within the Lati...

Peer comparison

Peers in the pharmaceutical industry typically report regional revenue to demonstrate geographic diversification and emerging market performance.

Metric ID: mrk_segment_latin_america_sales

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$532.00M$599.00M$506.00M$607.00M$642.00M$684.00M$649.00M$661.00M$742.00M$895.00M$788.00M$796.00M$858.00M$936.00M$869.00M$792.00M$859.00M$905.00M$854.00M$874.00M
QoQ Change+12.6%-15.5%+20.0%+5.8%+6.5%-5.1%+1.8%+12.3%+20.6%-12.0%+1.0%+7.8%+9.1%-7.2%-8.9%+8.5%+5.4%-5.6%+2.3%
YoY Change+20.7%+14.2%+28.3%+8.9%+15.6%+30.8%+21.4%+20.4%+15.6%+4.6%+10.3%-0.5%+0.1%-3.3%-1.7%+10.4%
Range$506.00M$936.00M
CAGR+11.0%
Avg YoY Growth+12.2%
Median YoY Growth+12.3%

Frequently Asked Questions

What is Merck & Co.'s latin america — sales?
Merck & Co. (MRK) reported latin america — sales of $874.00M in Q1 2026.
How has Merck & Co.'s latin america — sales changed year-over-year?
Merck & Co.'s latin america — sales increased by 10.4% year-over-year, from $792.00M to $874.00M.
What is the long-term trend for Merck & Co.'s latin america — sales?
Over 4 years (2021 to 2025), Merck & Co.'s latin america — sales has grown at a 11.5% compound annual growth rate (CAGR), from $2.21B to $3.41B.
What does latin america — sales mean?
The total revenue earned from business activities conducted in Latin American countries.